Live data · NADAC + Part D CY24 · reviewed daily

Risankizumab-Rzaa (Skyrizi)

Interleukin-23 Antagonist class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2021-04-26
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$4.58B in CY2024 Part D spend218K claims · 84K beneficiaries · 329 plans surveyed

Lowest NADAC
$9572.67/unit
3 NDCs benchmarked, lowest of all strengths.
Average NADAC
$18411.49
Across all dosage forms in distribution.
Highest NADAC
$22887.44
Range is tight.
Plans with PA
1212 / 329
Substantial PA friction across plans.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Risankizumab-Rzaa used for?

Risankizumab-Rzaa is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
Is there a generic for Risankizumab-Rzaa?

No. Risankizumab-Rzaa is brand-only with no generic equivalents currently in market.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
How much does my plan pay for Risankizumab-Rzaa?

Across 329 Part D plans, Risankizumab-Rzaa averages $18411.49/unit (NADAC). Lowest available: $9572.67/unit. Highest in distribution: $22887.44/unit.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
Is Risankizumab-Rzaa on the FDA shortage list?

No. Risankizumab-Rzaa is not currently on the FDA Drug Shortage Database.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.